Reply: Lorazepam-Induced Prolongation of the QT Interval in a Patient with Schizoaffective Disorder and Complete AV Block

Grohmann R Engel RR Rüther E Hippius H. The AMSP Drug Safety Program: Methods and global results. Pharmacopsychiatry 2004;37 (suppl 1):S4–S11.

Schmid C Grohmann R Engel RR Rüther E Kropp S. Cardiac adverse effects associated with psychotropic drugs. Pharmacopsychiatry 2004;37 (suppl 1):S65–S69.